DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Quadir - 2 Adtalem - 2 Sohn - 1 Eric Wolff - 1 Wolff - 1 Michelle Ross - 1 Cushing - 1 Ross - 1
Top related locs:
U.S New York Canada Las Vegas , Nevada Barbados Quadir Adtalem
Top related orgs:
Safkhet - 2 CNBC - 2 DeVry University - 2 Investment - 1 Gumshoe Capital Management Investment - 1 Pason Systems Energy - 1 Pason Systems - 1 Gumshoe Capital Management - 1

Search resuls for: "Fahmi Quadir"


3 mentions found


☆ Here are the top picks from rising hedge fund stars at Sohn, including one that could nearly double
  + stars: | 2024-04-03 | by ( Pia Singh Sarah Min | Pia Singh | Sarah Min | ) www.cnbc.com   time to read: +5 min
Hedge fund managers gathered Wednesday at the 2024 Sohn Investment Conference in New York to share their best investment ideas. It kicked off with "Next Wave Sohn," a session that features ideas from rising stars within the hedge fund industry. Endocrinology is an $8 billion market, but the cumulative market size, including the company's future therapy targets, is upward of $200 billion, which includes estimates for future obesity drugs, the investor said. It has CA$75 billion market cap with an "unbelievable record of success," according to the investor. The short seller noted that the company has a $5 billion market cap with about $4.8 billion of debt.
Persons: Sohn, Eric Wolff, Wolff, Michelle Ross, Cushing, Ross, Eli Lilly, Crinetics, XBI, Nikhil Daftary, Alimentation, Daftary, Chris Drose, Nate Koppikar, Fahmi Quadir Organizations: Investment, Gumshoe Capital Management Investment, Pason Systems Energy, Pason Systems, Gumshoe Capital Management, StemPoint, Pharmaceuticals, Crinetics Pharmaceuticals, StemPoint Capital, Endocrinology, Novo Nordisk, P Biotech, NK Capital Investment, NK Capital, Starbucks, McDonalds, Bleecker Street Capital, Orso Partners, Justice Department, Federal Trade Commission, Safkhet, Global Education Locations: New York, Canada, U.S
☆ Fahmi Quadir, short seller nicknamed 'The Assassin,' takes aim at for-profit college giant Adtalem
  + stars: | 2024-01-30 | by ( Eamon Javers | ) www.cnbc.com   time to read: +4 min
Quadir told CNBC she has a short position in the stock, meaning she is betting that the share price will decline. "We believe that Adtalem is completely uninvestable, the number of existential risks that exists today should cause alarm for any investor that's looking into this company," Quadir said. In 2017, DeVry Education changed its DV ticker symbol to Adtalem's current ATGE, completing the rebranding of DeVry into Adtalem. Quadir's report found that among Adtalem's properties, the online college Walden University has a graduation rate of just 29%. Adtalem's stock price has soared over 75% in just seven months, from just over $33 a share in late June, to more than $60 a share at Monday's open.
Persons: Quadir, Safkhet, Bridget Bennett, Rafael Henrique, Lightrocket, DeVry, Adtalem Organizations: Bloomberg, Getty Images WASHINGTON, Walden University, Chamberlain University, Ross University School of Medicine, CNBC, Safkhet, Netflix, Education, DeVry University, Cogswell Education, Blackrock, Vanguard, Department of Education, Higher Locations: Las Vegas , Nevada, U.S, Barbados, Quadir, Adtalem
☆ Short seller nicknamed ‘The Assassin' takes aim at for-profit college giant Adtalem
  + stars: | 2024-01-30 | by ( ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailShort seller nicknamed ‘The Assassin' takes aim at for-profit college giant AdtalemShort seller Fahmi Quadir has found her new target: the $2 billion market cap Adtalem Global Education. Adtalem is the successor to DeVry University, the for-profit education company that went public in 1991. In a new report exclusively obtained by CNBC, Quadir’s firm writes that Adtalem is “a toxic byproduct of an imperfect higher education system.”
Persons: Quadir, Adtalem Organizations: Adtalem, DeVry University, CNBC
0 next >>
Total: 3